Advanced Search
Submit ManuscriptADVANCE ONLINE PUBLICATION |
Sensing of DNA double-strand breaks by the NHEJ system stabilizes RORγt transcriptional activity and shapes Th17 pathogenicity in autoimmunity
Guan-Yu Chen1,† , Wen-Jie Zhu1,† , Zhuang Li1,† , Yun-Wei Hu1,2,† , Xiao-Shuang Luo1,† , Zhi-Qing Mai1 , Yuan Pan1 , Yu-Xun Shi1 , Zuo-Yi Li1 , Jun Huang1,2 , Pei-Dong Yuan1,3 , Zhi-Qiang Xiao1 , Qian Chen1,4 , Yan-Yan Xie1 , Hai-Xiang Huang1 , Yu-Xi Chen1 , Yao Lu1,5 , Min-Zhen Wang1 , Yi-Wen Xia1 , Xiao-Qing Chen1,* , Dong-Ming Kuang6,* , Dan Liang1,*
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, Guangdong, ChinaRobust mitochondrial ROS production induces extensive double-strand breaks (DSBs) in telomeric DNA of effector T cells, where the DNA repair machinery is rapidly hyper-evoked to sense and ligate DSBs during the respiratory burst. However, whether effector T cells can exploit the DNA repair system to simultaneously potentiate their functional activation remains largely unknown, especially in the context of autoimmunity. Here, we demonstrate that non-homologous end joining (NHEJ), a predominant mechanism of DNA repair, is highly activated in pathogenic T helper 17 (pTh17) cells and exerts a previously unrecognized effect on shaping the pathogenic nature of pTh17s to trigger autoimmunity. Mechanistically, the perception of DSBs by KU proteins facilitates auto-phosphorylation of DNA-dependent protein kinase catalytic subunit (DNA-PKcs), which stabilizes RORγt to bind to the promoters of effector-gene loci, thus initiating the pTh17 effector program to induce autoimmunity. Using mass spectrometry and transcriptome analyses, we identified IER2 as a novel NHEJ factor that potentiates DNA-PKcs kinase activity in response to IL-23R stimulation, which is necessary for shaping Th17 pathogenicity. Therefore, targeting the immuno-pattern of the NHEJ system shows potential for the treatment of autoimmune diseases.
https://doi.org/10.1038/s41422-025-01204-6